APA (7th ed.) Citation

AK, R., FS, M., RJ, C., J, D., PS, S., KP, D., . . . AC, C. (2025). Use of JYNNEOS (Smallpox and Mpox Vaccine, Live, Nonreplicating) for Persons Aged ≥18 Years at Risk for Mpox During an Mpox Outbreak: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023. MMWR. Morbidity and mortality weekly report, 74(22), 385. https://doi.org/10.15585/mmwr.mm7422a3

Chicago Style (17th ed.) Citation

AK, Rao, et al. "Use of JYNNEOS (Smallpox and Mpox Vaccine, Live, Nonreplicating) for Persons Aged ≥18 Years at Risk for Mpox During an Mpox Outbreak: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023." MMWR. Morbidity and Mortality Weekly Report 74, no. 22 (2025): 385. https://doi.org/10.15585/mmwr.mm7422a3.

MLA (9th ed.) Citation

AK, Rao, et al. "Use of JYNNEOS (Smallpox and Mpox Vaccine, Live, Nonreplicating) for Persons Aged ≥18 Years at Risk for Mpox During an Mpox Outbreak: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023." MMWR. Morbidity and Mortality Weekly Report, vol. 74, no. 22, 2025, p. 385, https://doi.org/10.15585/mmwr.mm7422a3.